Cerebral lupus in patients whilst on treatment for lupus nephritis with cyclosporine

Journal of Clinical Neuroscience

Volumn 10, Issue 1, 2003, Pages 104-106

  Hussein, M ^a   Mooij, J ^a   Roujouleh, H ^a  

^a AL HADA ARMED FORCES HOSPITAL   (Saudi Arabia)

Author keywords

Cerebral lupus; Cyclosporine; Lupus nephritis

Indexed keywords

ANTICONVULSIVE AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISONE;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ARTICLE; BRAIN DISEASE; CASE REPORT; CEREBRAL LUPUS; CLINICAL FEATURE; FEMALE; FOLLOW UP; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0037212237     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(02)00260-6     Document Type: Article

References (15)

1. Boumpas DT, Austin III HA, Fessler BJ, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts, Part 1: Renal. Neuropsychiatric, cardiovascular, pulmonary, and haematologic disease. Ann Intern Med 1995: 122: 940-950.
2. Langford CA, Klippel JH, Balow JE, James SP, Sneller MC. Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Ann Intern Med 1998: 128: 1021-1028.
3. Mitchell I, Webb M, Hughes R, Maisey M, Cameron JS. Cerebral lupus. Lancet 1994: 343: 579-582.
4. Neuwelt CM, Lacks S, Kaye BR, Ellman JB, Borenstein DG. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med 1995; 98: 32-41.
5. Galindo-Rodriguez G, Avina-Zubieta JA, Pizarro S, Diaz de Leon V, Saucedo N, Fuentes M, Lavalle C. Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: An open trial. Am J Med 1999; 106(1): 65-69.
6. Favre H, Miescher PA, Huang YP, Chatelanat F, Mihatsch MJ. Cyclosporin in the treatment of lupus nephritis. Am J Nephrol 1989; 9(suppl I): 57-60.
7. Hussein MM, Mooij J, Roujouleh H. Cyclosporine in the treatment of lupus nephritis including two patients with pregnancy. Clin Nephrol 1993: 40: 160-163.
8. Radhakrishan J, Valeri A, Kunis C, Appel GB. Use of cyclosporine in lupus nephritis. In: Tejani E, editor. Cyclosporine in the Therapy of Renal Disease. Basel, Karger. Contrib Nephrol 1995: 114: 59-72.
9. Caccavo D, Lagana B, Mitterhofer AP, Ferri GM, Afeltra A, Amoroso A, Bonomo L. Long-term treatment of systemic lupus erylhematosus with cyclosporine A. Arthritis Rheum 1997: 40: 27-35.
10. Klein M, Radhakrishnan J, Appel G. Cyclosporine treatment of glomerular diseases. Annu Rev Med 1999: 50: 1-15.
11. Morton SJ, Powell RJ. An audit of cyclosporin for systemic lupus erythematosus and related overlap syndromes: Limitations of its use. Ann Rheum Dis 2000; 59: 487-489.
12. Blank M, Ben Bassat M, Shoenfeld Y. The effect of cyclosporin A on early and late stages of experimental lupus. Arthritis Rheum 1992: 35: 1350-1355.
13. Bergijk EC, Baelde HJ, De Heer E, Bruijn JA. Prevention of glomerulosclerosis by early cyclosporine treatment of experimental lupus nephritis. Kidney Int 1994; 46: 1663-1673.
14. Cameron JS. Lupus nephritis. J Am Soc Nephrol 1999: 10: 413-424
15. Bruyn GA. Controversies in lupus: Nervous system involvement. Ann Rheum Dis 1995; 54: 159-167.